{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A Survey of Healthcare Practitioners in India on the Epidemiology and Treatment Options for Atopic Dermatitis

Survey Questionnaire Form
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. What is the age range of most of your AD (Atopic dermatitis) patients? *

  2. Which gender do you most commonly observe being affected by AD in your clinical practice? *

  3. Which diagnostic methods do you primarily use for atopic dermatitis? *

  4. How do you rate the impact of atopic dermatitis on patients' quality of life? *

  5. What are the most common challenges you face when treating AD? *
  6. What factors do you consider when choosing a treatment plan for AD? *
  7. What is your primary treatment modality for AD? *

  8. What role do you believe emollients play in the management of AD? *
  9. What is the most common side effect you observe with topical corticosteroid use? *

  10. How do you address patient concerns regarding the long-term use of topical corticosteroids? *
  11. What are your thoughts on the effectiveness of systemic therapies for AD? *
  12. How satisfied are you with the current treatment options for AD? *
  13. Do you recommend phototherapy for atopic dermatitis patients? *

  14. What percentage of your AD patients experience severe symptoms? *

  15. How often do you recommend lifestyle modifications to your AD patients? *

  16. What is your preferred method for monitoring treatment efficacy? *

  17. How do you assess the severity of atopic dermatitis in your patients? *

  18. What is your primary concern regarding long-term treatment of AD? *

  19. How is your experience with biologic treatments for AD? *
  20. What percentage of your atopic dermatitis patients experience comorbid conditions (e.g., asthma, allergic rhinitis)? *

  21. What is the most common comorbidity you observe in AD patients? *

  22. What are the common triggers for atopic dermatitis flare-ups in your patients?*
  23. How do you typically manage AD flare-ups? *

  24. Do you consider dietary modifications as part of the treatment plan for atopic dermatitis? *

  25. Is there any co-relation of seasonality and flare-ups going up for AD patients? *

  26. Which time period of the year (listed below) you have observed more number of patients complaining about flare-ups increasing for AD patients? (can select multiple option) *

  27. What is your experience with patient adherence to AD treatment plans? *

  28. How do you prioritize treatment goals for AD patients? *

  29. How often do you encounter treatment-resistant AD cases? *

  30. How do you feel about the role of genetics in AD management? *
  31. Which type of moisturizers do you use in the management of AD? *

  32. How has your experience been with the use of ceramide-based moisturizers in the management of atopic dermatitis? *
  33. How often do you prescribe crisaborole for atopic dermatitis? *

  34. What do you consider the most significant advantage of crisaborole over traditional treatments? *

  35. How do you compare the efficacy of crisaborole to topical corticosteroids? *

  36. How do you perceive the role of crisaborole in the treatment hierarchy for atopic dermatitis? *

  37. Do you collaborate with other specialists (e.g., allergists, immunologists) in managing atopic dermatitis? *

  38. How do you approach the management of AD in paediatric patients? *
  39. Describe any recent advancements in AD treatment that you find promising. *
  40. Can you share any case example where a particular treatment significantly improved a patient's condition? *